v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue    
Revenue
Total revenue
Cost of goods sold    
Cost of goods sold
Total cost of goods sold
Gross profit
Operating expenses    
Research and development 552,126 369,933
General and administrative 1,413,592 820,712
Total operating expenses 1,965,718 1,190,645
Loss from operations (1,965,718) (1,190,645)
Other income (expense), net    
Interest expense, net (3,273) (60,281)
Loss on conversion of notes (92,959)
Interest income 65,197 18,338
Total other income (expense), net 61,924 (134,902)
Net loss (1,903,794) (1,325,547)
Deemed dividend related to warrant exercise price adjustment (16,774)
Net loss attributatble to common stockholders $ (1,920,568) $ (1,325,547)
Net loss per common share attributable to common stockholders - basic $ (0.26) $ (0.27)
Net loss per common share attributable to common stockholders - diluted $ (0.26) $ (0.27)
Weighted average number of shares outstanding - basic 7,388,508 4,840,023
Weighted average number of shares outstanding - diluted 7,388,508 4,840,023

Source